How was Adimmune's revenue in March 2026?

It was TWD 65.48 million, a record growth of +2102.7% year-over-year.

Why did Adimmune's revenue surge so much?

This is because revenue in the same month last year was extremely low, and revenue from vaccine shipments and contract manufacturing was recognized this month. The fact that there was revenue is more important than the growth rate figure itself.

Is Adimmune's business stable?

Monthly revenue fluctuates significantly, but this is characteristic of a business that produces and ships based on contracts. It needs to be evaluated on a quarterly or full-year basis.

AI News NQ Analysis

【Adimmune】March 2026 Revenue NT$65 Million (YoY +2102.7%)

NQ Score 5/100

N1 Content Completeness 5

AI Summary (NQ-processed)

Adimmune's revenue for March 2026 was NT$65 million, a staggering increase of +2102.7% year-over-year. The company is in the Biotechnology and Medical Care industry.

AI Analysis

Frequently Asked Questions

Q: How was Adimmune's revenue in March 2026?: A: It was TWD 65.48 million, a record growth of +2102.7% year-over-year.
Q: Why did Adimmune's revenue surge so much?: A: This is because revenue in the same month last year was extremely low, and revenue from vaccine shipments and contract manufacturing was recognized this month. The fact that there was revenue is more important than the growth rate figure itself.
Q: Is Adimmune's business stable?: A: Monthly revenue fluctuates significantly, but this is characteristic of a business that produces and ships based on contracts. It needs to be evaluated on a quarterly or full-year basis.